BWM
ELVN icon

Baystate Wealth Management’s Enliven Therapeutics ELVN Stock Holding History

Baystate Wealth Management’s Portfolio ELVN Stock Details ELVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		$692 Hold
50
– – ﹤0.01% 1182
2023
Q3 		$683 Hold
50
– – ﹤0.01% 919
2023
Q2 		$1.02K Hold
50
– – ﹤0.01% 930
2023
Q1 		$1.1K Buy
+50
New +$1.1K ﹤0.01% 921